Jagsonpal Pharmaceuticals has completed acquisition of 69.77% equity stake in Aequitas Healthcare (Aequitas), out of a proposed 85% stake. Consequently, Aequitas has become a subsidiary of the Jagsonpal Pharmaceuticals. The acquisition marks the company’s strategic entry into the hospital segment and is aligned with the company's long-term vision of strengthening its presence in India’s growing healthcare ecosystem.
Earlier, the company had entered into a definitive agreement for the acquisition of 85% equity stake in Aequitas, a Mumbai-based pharmaceutical company primarily focused on sale and distribution of pharmaceutical products to hospitals.
Jagsonpal Pharmaceuticals is among India’s premiere pharmaceutical companies. The company has substantial research and development, manufacturing, marketing and distribution facilities.
